Financial News
DateTitlemore >
Jul. 21, 2008250 Amgen Scholars from 10 Premier Universities Convene for National Summer Symposium to Explore Drug Discovery & Development
Jul. 17, 2008Amgen Announces Webcast of 2008 Second Quarter Financial Results
Jul. 15, 2008Study Showed Half of Patients Treated with Enbrel(R) (etanercept) Plus Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had No Progression of Joint Damage in Active Early Rheumatoid Arthritis
Jul. 14, 2008Amgen Announces Positive Top-Line Results for Denosumab Treatment of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing Androgen Deprivation Therapy
Jul. 11, 2008Amgen and Ortho Biotech Settle Antitrust Suit
Jul. 10, 2008Amgen Commits to PhRMA's Enhanced Code on Interactions with Healthcare Professionals as Part of the Company's 'Clearly Amgen' Initiative
Related Links Stock Quote


AMGN: NASDAQ
$53.84

 (Minimum 20 minute delay)